Odawara, Japan

Takuo Tsukuda

USPTO Granted Patents = 14 


Average Co-Inventor Count = 7.3

ph-index = 4

Forward Citations = 261(Granted Patents)


Location History:

  • Yokohama, JP (1995 - 1998)
  • Kita-ku, JP (2008)
  • Kamakura, JP (2010)
  • Kanagawa, JP (2011 - 2013)
  • Odawara, JP (2001 - 2014)

Company Filing History:


Years Active: 1995-2014

Loading Chart...
Loading Chart...
14 patents (USPTO):

Title: Takuo Tsukuda: Innovator in Nucleoside Derivatives and Anti-Cancer Compounds

Introduction

Takuo Tsukuda is a prominent inventor based in Odawara, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of nucleoside derivatives and compounds with anti-cancer properties. With a total of 14 patents to his name, Tsukuda's work has had a substantial impact on medical research and treatment options.

Latest Patents

Among his latest patents, Tsukuda has developed 4'-substituted nucleoside derivatives as inhibitors of HCV RNA replication. This invention relates to the use of nucleoside derivatives of a specific formula, along with pharmaceutically acceptable salts and compositions containing these compounds. Additionally, he has created a novel class of macrocyclic compounds that inhibit the HSP90 enzyme, which are useful as anti-cancer agents. These compounds are represented by a defined formula and include pharmaceutically acceptable salts.

Career Highlights

Throughout his career, Takuo Tsukuda has worked with notable companies such as Chugai Pharmaceutical Co., Ltd. and Roche Palo Alto LLC. His experience in these organizations has allowed him to collaborate on groundbreaking research and development projects that advance the field of medicine.

Collaborations

Tsukuda has collaborated with esteemed colleagues, including Nobuo Shimma and Susumu Komiyama. These partnerships have fostered innovation and contributed to the success of his inventions.

Conclusion

Takuo Tsukuda's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as a key innovator. His work continues to influence the development of new treatments and therapies in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…